Sales rise 29.15% to Rs 74.69 crore
Net profit of Jagsonpal Pharmaceuticals rose 53.41% to Rs 11.46 crore in the quarter ended September 2024 as against Rs 7.47 crore during the previous quarter ended September 2023. Sales rose 29.15% to Rs 74.69 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales74.6957.83 29 OPM %21.8114.47 -PBDT17.7110.42 70 PBT15.379.96 54 NP11.467.47 53Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Stock market")
 "India vs New Zealand 2nd Test live score updates")
 "India bonds, mmarket, stock market")
 "Deepak builder ipo allotment status")
 "Chancellor Olaf Scholz, PM Modi")
